Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China flag China · Delayed Price · Currency is CNY
14.75
-0.30 (-1.99%)
Nov 18, 2026, 3:00 PM CST

SHA:600671 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
202.59211.75217.3121.78108.91147.07
Revenue Growth
-19.46%-2.55%78.44%11.82%-25.95%-28.82%
Gross Profit
99.87100.16100.6823.4115.1640.62
Operating Income
18.814.0429.44-22.5-43.89-29.19
Net Income
11.5217.6215.25-38.28-67.52-29.8
Earnings Per Share
0.090.140.13-0.31-0.55-0.24
EPS Growth
-65.29%15.57%----

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Chinese Patent Medicine
28.26
Chemical Medicine
1.84
Active Pharmaceutical Ingredient (API)
30.3
Health Care Products
90.99
Circulating Commodities
50.35
Medical Instruments
3.79
Service Type
5.19
Other
0.98
Total
211.7

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
36.3931.8965.7297.9642.3922.29
Total Debt
158.9165.79152.35114.61116.04113.7
Net Cash (Debt)
-122.51-133.91-86.63-16.65-73.65-91.41
Net Cash Growth
------
Net Cash Per Share
-1.01-1.10-0.71-0.14-0.60-0.74

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
64.3311.79-36.67-20.43-19.37-26.42
Capital Expenditures
-14.57-31.18-20.55-8.96-3.52-4.71
Free Cash Flow
49.76-19.39-57.23-29.38-22.89-31.13
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.30%47.30%46.33%19.23%13.92%27.62%
Operating Margin
9.28%6.63%13.55%-18.48%-40.30%-19.85%
Pretax Margin
5.55%4.83%13.38%-29.82%-66.45%-22.94%
Profit Margin
5.69%8.32%7.02%-31.43%-62.00%-20.26%
FCF Margin
24.56%-9.16%-26.34%-24.13%-21.02%-21.17%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
155.90119.6270.13---
PS Ratio
9.059.964.9211.6610.637.44